The first-in-human study is testing an ascending-dose microneedle device designed to deliver peanut protein through the skin in just 3 minutes.
Brian P. Vickery, MD
Advertisement
Brian Vickery, MD, chief of allergy and immunology at Children's Healthcare of Atlanta.
Articles by Brian P. Vickery, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Investigational Rapid-Acting U500 Insulin Maintains Efficacy Regardless of BMI
2
Q&A: Rethinking Early Systemic Therapy for Hidradenitis Suppurativa
3
Skin of Color Savvy: Mentorship in Dermatology—Building the Next Generation of Leaders
4
The HCPFive: Top News for Healthcare Providers from the Week of 08/09
5